Novel levodopa formulations in the treatment of Parkinson's disease.

Novel levodopa formulations in the treatment of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q38178754
Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.Rational drug discovery design approaches for treating Parkinson's disease.Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's Disease.Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Parkinson's disease, antiparkinson medicines, and driving.Nondopaminergic therapy of motor and nonmotor symptoms in Parkinson's disease: a clinician's perspective.DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons.Extended-release oral capsule of carbidopa-levodopa in Parkinson disease.Treatment of advanced Parkinson's disease.
P2860

Novel levodopa formulations in the treatment of Parkinson's disease.

Item
http://www.wikidata.org/entity/Q38178754
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel levodopa formulations in the treatment of Parkinson's disease.
@en
type
label
Novel levodopa formulations in the treatment of Parkinson's disease.
@en
prefLabel
Novel levodopa formulations in the treatment of Parkinson's disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Novel levodopa formulations in the treatment of Parkinson's disease.
@en
P2093
P2860
P304
P31
P356
10.1586/14737175.2014.877840
P433
P478
P50
P577
P5875
P698
P921